Medtech: In the 21st century, ‘Artificial Intelligence (AI)’ is not a buzzword—it is the brain of modern medicine. As the ...

The FDA told Regeneron in a complete response letter that while it didn't identify any issues with the safety or efficacy of the drug in its approved indications and dosing regimens, the agency didn't ...

Dr. Michael Kapusta, MD, FRSCS, Ophthalmologist, talks about advanced (proliferative) diabetic retinopathy and pars plana ...

With vision loss due to diabetes emerging as one of the most serious yet overlooked complications in India, Firstpost brings ...

A group of 18 African ophthalmologists have successfully completed a one-year specialized training program in Diabetic ...

Diabetes affects more than 101 million people in India today. The number is estimated to reach 125 million by the year 2045.

The global optical coherence tomography (OCT) devices market is witnessing remarkable growth and is anticipated to reach a market value of USD 2.87 billion by 2032, up from USD 1.30 billion in 2023.

The global Diabetic Retinopathy Market is valued at USD 9.1 Billion in 2024 and is projected to reach a value of USD 15.1 ...

Emergen Research Logo The development of anti-VEGF therapies, which inhibit the growth of abnormal blood vessels in the retina, reduces the ...

Topcon Corp., Carl Zeiss, Robert Bosch, Verily Life Sciences (Alphabet), and NIDEK CO. are Among the Leading PlayersDublin, April 08, 2025 (GLOBE NEWSWIRE) -- The "Nonmydriatic Handheld Fundus Cameras ...

AI is transforming rural healthcare in India—from diabetic screenings in tribal villages to preventing childhood blindness.

Diabetic retinopathy affects 30 lakh Indians and can lead to vision loss. Advanced therapies include costly injections currently not covered under Centre’s healthcare scheme.